Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Yabao Pharmaceutical Research and Development is the primary innovative drug discovery and development subsidiary of Yabao Pharmaceutical Group. Located in the Suzhou Biobay hub, the company focuses on the creation of novel small molecule and biologic therapies targeting oncology, metabolic disorders, and cardiovascular health. The center integrates advanced medicinal chemistry, pharmacology, and translational medicine to advance its internal pipeline from early discovery through clinical proof-of-concept. Suzhou Yabao has established significant global partnerships, including collaborations with major pharmaceutical companies and academic institutions, to accelerate its R&D programs. Its strategic location and robust infrastructure support Yabao's transition into a leading innovation-driven biopharmaceutical enterprise in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Yabao Pharmaceutical Research and Development.